menu
    • menu
    [{"orgOrder":0,"company":"Hamlet Pharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"SWEDEN","productType":"Peptide","year":"2023","type":"Inapplicable","leadProduct":"Alpha1H","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase I\/ Phase II","graph3":"Hamlet Pharma","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Intravesical Solution","sponsorNew":"Hamlet Pharma \/ Inapplicable","highestDevelopmentStatusID":"7","companyTruncated":"Hamlet Pharma \/ Inapplicable"}]

    Find Clinical Drug Pipeline Developments & Deals by Hamlet Pharma

    Menu

    Hamlet Pharma

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Hamlet Pharma

                            Sweden arrow
                            ACS GCI
                            Not Confirmed

                            Hamlet Pharma

                            Sweden arrow
                            ACS GCI
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Alpha1H

                            Therapeutic Area : Oncology

                            Study Phase : Phase I/ Phase II

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            FDA Clearance of IND Application for Alpha1H for the Treatment of Non-muscle Invasive Bladder Cancer

                            Details : Alpha1H attacks the cell membrane from the outside, enters the tumor cells and quickly migrates into the cell nucleus, where vital functions are inhibited in cancer cells, which is investigated for treatment of non-muscle invasive bladder cancer.

                            Product Name : Alpha1H

                            Product Type : Peptide

                            Upfront Cash : Inapplicable

                            January 07, 2023

                            Lead Product(s) : Alpha1H

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase I/ Phase II

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth